TOOKAD 183 mg powder for solution for injection, PADELIPORFIN
CLIN2001UCM301
Phase 3 small_molecule active
Quick answer
TOOKAD 183 mg powder for solution for injection, PADELIPORFIN for Low Grade Upper Tract Urothelial Cancer is a Phase 3 program (small_molecule) at STEBA Biotech S.A with 1 ClinicalTrials.gov record(s).
Program details
- Company
- STEBA Biotech S.A
- Indication
- Low Grade Upper Tract Urothelial Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active